Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Cancer Medicine|January 24, 2013
Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkersEkaterina Olkhov-Mitsel, Bharati BapatCancers|November 14, 2023
<i>MLH1</i> Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening-A Critical AppraisalAnna Plotkin, Ekaterina Olkhov-Mitsel, Sharon Nofech-MozesAmerican Journal of Clinical Pathology|February 7, 2023
The Impact of the Pathologist in Multidisciplinary Cancer Conferences on Patient Care : Evidence From the LiteratureAnna Plotkin, Ekaterina Olkhov-Mitsel, Anna R GagliardiCancers|June 19, 2024
Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer CenterAnna Plotkin, Ekaterina Olkhov-Mitsel, Weei-Yuarn Huang, et al.Analytical Chemistry|March 7, 2013
Measuring kinetic isotope effects in enzyme reactions using time-resolved electrospray mass spectrometryPeter Liuni, Ekaterina Olkhov-Mitsel, Arturo Orellana, et al.The American Journal of Surgical Pathology|July 15, 2026
Uterine Leiomyomas Presenting During Pregnancy and Delivery: Comprehensive Characterization of Features Helpful in the Distinction From Malignant MimicsEkaterina Olkhov-Mitsel, Yutaka Amemiya, Arun Seth, et al.Pathology, Research and Practice|September 11, 2021
Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinomaYouheng Xie, Ekaterina Olkhov-Mitsel, Samira Alminawi, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 16, 2025
Napsin-A Expression in Mesonephric and Mesonephric-like Adenocarcinomas: Implications for Distinction From Clear Cell CarcinomaJelena Mirkovic, Ekaterina Olkhov-Mitsel, Sharon Nofech-Mozes, et al.Cancers|June 26, 2026
Evaluating HER2 Scoring Criteria in Endometrial Carcinoma: Gynecologic Versus Gastric Guidelines for Trastuzumab and Trastuzumab-Deruxtecan SelectionSharon Nofech-Mozes, Ekaterina Olkhov-Mitsel, Fang-I Lu, et al.Journal of Clinical Pathology|January 26, 2019
International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcomeAnjelica Hodgson, Ekaterina Olkhov-Mitsel, Brooke E Howitt, et al.Pageof 6